FDA Approves Revolutionary Alzheimer’s Drug, Leqembi, Shaking Up the Medical Field

In a groundbreaking move, the U.S. Food and Drug Administration (FDA) has recently granted full approval to Leqembi (pronounced lah-kem-be), a potential game-changing drug for the treatment of Alzheimer's disease. Unlike previously approved medications that primarily focused on managing the symptoms of this debilitating condition. . .